FEMSCI LIMITED

Executive Summary

FEMSCI LIMITED currently operates as a dormant company with stable but inactive financial health, maintaining net assets equal to initial share capital and no trading activity. The company is administratively compliant but lacks operational vitality, presenting both a low-risk status and a need for strategic direction if it aims to activate business operations. Careful planning and capital allocation will be essential to transition into a financially healthy, active company.

FEMSCI LIMITED - Analysis Report

Company Number: 14905362

Analysis Date: 2025-07-29 17:51 UTC

Financial Health Assessment for FEMSCI LIMITED

---

1. Financial Health Score: C

Explanation:
FEMSCI LIMITED shows characteristics of a dormant company with minimal financial activity. The company's net assets and shareholders' funds hold steady at £10,000 over three years, indicating no operational earnings or losses. This steady but stagnant position reflects "stable but inactive" financial health—a state akin to a patient with stable vital signs but no active metabolism. The company is not generating cash flow or operating profit, which limits growth potential but also reduces immediate financial risks.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active, Dormant	No active trading or revenue generation, no financial distress
Net Assets (2023-2025)	£10,000	Constant net asset value shows no operational activity or losses
Shareholders' Funds	£10,000	Equity remains intact, indicating no erosion of capital
Profit & Loss Activity	None (Dormant)	No trading or profit/loss reported
Filing Compliance	Up to date	No overdue filings, indicating administrative health
Ownership	Single PSC (75-100% shares)	Clear control structure, but high concentration risk
Industry Classification	R&D, IT consultancy, Precision instruments	Potentially high-tech sectors, but no active commercial operations

---

3. Diagnosis

FEMSCI LIMITED is currently in a dormant state, showing no symptoms of financial distress such as negative net assets, liabilities exceeding assets, or overdue filings. The company’s "vital signs" are stable but reflect a lack of operational activity. This can be likened to a patient in remission or hibernation—stable, but not actively growing or generating income.

The constant net assets of £10,000 represent the initial share capital, with no indication of business expansion or investment. The company has neither reported any revenue nor expenses, adhering to dormant status under Companies Act exemptions. This means the company is not currently engaging in trading activities or commercial operations.

The presence of a single individual holding majority control (75-100% shares) simplifies decision-making but also concentrates risk of governance. The company's registered address and director details suggest a minimal operational footprint.

---

4. Recommendations

• Activate Operations or Maintain Dormancy with Purpose: If the company plans to begin trading, develop a detailed business plan to transition from dormancy to active status, including budgeting for R&D and operational costs in the sectors identified (IT consultancy, precision instruments, scientific R&D).

• Regular Monitoring: Maintain strict compliance with filing and legal obligations to avoid penalties or complications. Dormant companies must keep proper records even without trading.

• Capital Injection if Scaling: If activation is planned, consider additional equity or funding to support initial operations, as existing capital (£10,000) may be insufficient for R&D or consultancy activities.

• Risk Management: Given the sole ownership, implement strong governance practices to mitigate risks linked to control concentration.

• Strategic Review: Evaluate the business environment and market opportunities in relevant SIC sectors to determine the viability of moving from dormancy to active trading.

---